Follow
Daniel Gallacher
Title
Cited by
Cited by
Year
Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses
T Rowland, BI Perry, R Upthegrove, N Barnes, J Chatterjee, D Gallacher, ...
The British Journal of Psychiatry 213 (3), 514-525, 2018
1602018
Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysis
R Mottram, WL Knerr, D Gallacher, H Fraser, L Al-Khudairy, A Ayorinde, ...
BMJ open 11 (11), 2021
292021
Extrapolating Parametric Survival Models in Health Technology Assessment: A Simulation Study
D Gallacher, P Kimani, N Stallard
Medical Decision Making 41 (1), 37-50, 2020
262020
Mode of birth and development of maternal postnatal post‐traumatic stress disorder: A mixed‐methods systematic review and meta‐analysis
J Carter, D Bick, D Gallacher, YS Chang
Birth 49 (4), 616-627, 2022
192022
How do pharmaceutical companies model survival of cancer patients? A review of NICE single technology appraisals in 2017
D Gallacher, P Auguste, M Connock
International journal of technology assessment in health care 35 (2), 160-167, 2019
192019
Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation
Fraser H, Gallacher D, Achana F, Court R, Taylor-Phillips S, Nduka C ...
Health Technology Assessment 24 (31), 2020
18*2020
Derivation and internal validation of the screening to enhance prehospital identification of sepsis (SEPSIS) score in adults on arrival at the emergency department
MA Smyth, D Gallacher, PK Kimani, M Ragoo, M Ward, GD Perkins
Scandinavian journal of trauma, resuscitation and emergency medicine 27, 1-13, 2019
172019
Efficacy, safety, and dose‐dependence of the analgesic effects of opioid therapy for people with osteoarthritis: systematic review and meta‐analysis
C Abdel Shaheed, W Awal, G Zhang, SE Gilbert, D Gallacher, ...
Medical Journal of Australia 216 (6), 305-311, 2022
152022
Pembrolizumab for previously treated advanced or metastatic urothelial cancer: an evidence review group perspective of a NICE single technology appraisal
D Gallacher, X Armoiry, P Auguste, R Court, T Mantopoulos, J Patterson, ...
PharmacoEconomics 37, 19-27, 2019
132019
Court R, Taylor-Phillips S, Nduka C, et al. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and …
H Fraser, D Gallacher, F Achana
Health Technol Assess 24 (31), 1-232, 2020
122020
A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and …
D Gallacher, P Auguste, P Royle, H Mistry, X Armoiry
Clinical Drug Investigation 39 (12), 1153-1174, 2019
92019
Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2+/− Mice Is Superior to Everolimus Alone
J Yang, PA Samsel, K Narov, A Jones, D Gallacher, J Gallacher, ...
Neoplasia 19 (2), 112-120, 2017
92017
Assessing the health economic agreement of different data sources
D Gallacher, F Achana
Stata Journal 18 (1), 223-233, 2018
82018
Extrapolating Parametric Survival Models in Health Technology Assessment Using Model Averaging: A Simulation Study
D Gallacher, P Kimani, N Stallard
Medical Decision Making 41 (4), 476-484, 2021
72021
Systematic review and meta‐analysis of the metabolic effects of modified‐release hydrocortisone versus standard glucocorticoid replacement therapy in adults with adrenal …
CA Bannon, D Gallacher, P Hanson, HS Randeva, MO Weickert, ...
Clinical Endocrinology 93 (6), 637-651, 2020
72020
Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data
F Achana, D Gallacher, R Oppong, S Kim, S Petrou, J Mason, M Crowther
Medical Decision Making 41 (6), 667-684, 2021
52021
Ankle injury rehabilitation (AIR): a feasibility randomised controlled trial comparing functional bracing to plaster cast in the treatment of adult ankle fractures
RS Kearney, R McKeown, D Gallacher, J Brown, D Mistry, N Parsons, ...
Pilot and Feasibility Studies 5 (1), 1-8, 2019
52019
Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations
D Gallacher, P Kimani, N Stallard
PharmacoEconomics, 1-12, 2022
32022
Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost‐effectiveness assessment on health utility for targeted medicines
D Gallacher, N Stallard, P Kimani, E Gökalp, J Branke
Health Economics 31 (2), 417-430, 2022
2*2022
HEABS: Stata module to calculate the ICER and Net Benefit for up to two datasets
D Gallacher
Boston College Department of Economics, 2020
22020
The system can't perform the operation now. Try again later.
Articles 1–20